As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
It’s hard to make international comparisons of the COVID death rates in individual countries, but a new approach is giving scientists better data to work with.
A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
Epidemiologists reviewed 25 studies of cloth face masks. Here’s what they found out about how well they work, why they work, who they protect and why the mosquito and chain-link fence analogy is wrong.
It is vital that the latest move by government towards restructuring succeeds in making the industry safe, reliable and viable, contributing to the country’s economy.
With lives depending on a vaccine, trust in Canada’s COVID-19 Vaccine Task Force is crucial. Members of the task force need to make any industry links or potential conflicts of interest publicly clear.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
How do you run a political campaign in a pandemic? From data brokers to advertising firms to voter registration volunteers, the players in campaigns are making adjustments, large and mostly small.
While restrictions on civil and political liberties may be necessary to protect lives, human rights law requires that they go no further than what’s strictly necessary to achieve this goal.